Alev Gurgun

Alev Gurgun

Auto-generated profile, based on publicly available information

Alev Gurgun

Department of Chest Diseases Ege University Faculty of Medicine İzmir Türkiye

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Turkish Journal of Emergency Medicine
Verified
Journal Article
Open access
PDF file
NDNurettin Özgür Doğan
Nurettin Özgür Doğan
YVYelda Varol
Yelda Varol
NKNurdan Kokturk
Nurdan Kokturk
EAErsin Aksay
Ersin Aksay
AAAylin Ozgen Alpaydin
Aylin Ozgen Alpaydin
MPMehmet Polatlı
Mehmet Polatlı
Chronic obstructive pulmonary disease (COPD) is an important public health problem that manifests with exacerbations and causes serious mortality and morbidity in both developed and developing countries. COPD exacerbations usually present to emergency departments, where these patients are diagnosed and treated. Therefore, the Emergency Medicine Association of Turkey and the Turkish Thoracic Society jointly wanted to implement a guideline that evaluates the management of COPD exacerbations according to the current literature and provides evidence-based recommendations. In the management of COPD exacerbations, we aim to support the decision-making process of clinicians dealing with these patients in the emergency setting.

10 December 2020 in Turkish Thoracic Journal
Verified
Journal Article
Closed access
NKNurdan Kokturk
Nurdan Kokturk
BIBahriye Oya Itil
Bahriye Oya Itil
GAGoksel Altinisik
Goksel Altinisik
NANalan Adiguzel
Nalan Adiguzel
MAMetin Akgün
Metin Akgün
TCTurkish Thoracic Society COVID-19 Follow-Up Committee
Turkish Thoracic Society COVID-19 Follow-Up Committee
COVID-19 pandemic,Turkish Thoracic Society,social determinants of health,national lung health,clinical trials

15 August 2023 in Thoracic Research and Practice
Verified
Journal Article
Open access
SDSami Deniz
Sami Deniz
STSenay Tuncel
Senay Tuncel
AGAlev Gurgun
Alev Gurgun
FEFunda Elmas
Funda Elmas
COPD management,exercise training,non-invasive ventilation

1 December 2025 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
ABAyse Baha
Ayse Baha
CBCaner Baysan
Caner Baysan
SNSibel Nayci
Sibel Nayci
EOEylem Ozgur
Eylem Ozgur
TKTugce Karamustafalioglu
Tugce Karamustafalioglu
OHOsman Hilmioglu
Osman Hilmioglu
Objective: The Rome classification was introduced to assess the severity of acute exacerbation (AE) of chronic obstructive pulmonary disease (COPD) based on easily measurable variables. However, its validation for global use has not yet reached a sufficient level. This study aims to evaluate the validity of the Rome criteria in determining the severity and prognosis of COPD AE in Turkey. Methods: This multicenter study, conducted for the first time in Turkey and for the fourth time worldwide, included 750 patients diagnosed with AE-COPD who presented to emergency departments and outpatient clinics. According to the Rome criteria, patients were classified into three groups: mild, moderate, and severe AE-COPD. Results: The study included 99 (13.2%) patients in the mild, 479 (63.9%) in the moderate, and 172 (22.9%) in the severe group. Emergency visits, hospitalizations, and ICU admissions in the past year were more frequent in the moderate and severe groups (p < 0.001 for all comparisons). Regarding outcomes of emergency or outpatient visits, most mild exacerbation cases were discharged (p < 0.001), while most moderate and severe exacerbations required hospitalization (p < 0.001). Compared to the moderate group, the severe exacerbation group had a higher risk of ICU admission (p < 0.001), NIV (p < 0.001), IMV (p < 0.001), in-hospital mortality (p < 0.001), and 30-day mortality (p = 0.015). No significant differences were found in 90-day mortality or 30 and 90-day readmission rates (p = 0.258, p = 0.712, p = 0.681, respectively). Survival analysis revealed no significant difference between the moderate and severe groups (p = 0.764). Conclusion: The findings suggest that the Rome criteria can be successfully used to assess exacerbation severity in AE-COPD patients presenting to secondary and tertiary care hospitals in Turkey.

10 January 2024 in Thoracic Research and Practice
Verified
Journal Article
Open access
ABAyşe Baha
Ayşe Baha
NKNurdan Kokturk
Nurdan Kokturk
CBCaner Baysan
Caner Baysan
BÖBurcu Öztürk
Burcu Öztürk
SCSümeyye Kodalak Cengiz
Sümeyye Kodalak Cengiz
AAAylin Ozgen Alpaydin
Aylin Ozgen Alpaydin
COPD,severe exacerbation,costs,discharge,antibiotic,nutrition,pulmonary rehabilitation

1 October 2015 in Chest
Verified
Journal Article
Open access
AGAlev Gurgun
Alev Gurgun
STSenay Tuncel
Senay Tuncel
HKHale Karapolat
Hale Karapolat
HUHatice Uluer
Hatice Uluer
SESSION TITLE: Pulmonary Rehabilitation SESSION TYPE: Original Investigation Slide PRESENTED ON: Monday, October 26, 2015 at 07:30 AM - 08:30 AM PURPOSE: We evaluated the effects of non-invasive ventilation (NIV) and supplemental oxygen during exercise training (ET+NIV+O2), in comparison with supplemental oxygen exercise training (ET+O2) and exercise trainig (ET) alone groups on lung functions, blood gas analysis, lactate levels, respiratory muscle strength, dyspnea, exercise capacity, health status, anxiety and depression in patients with severe COPD. METHODS: 35 patients (mean age 65.4 ± 6.5 yrs) with COPD (mean FEV1 39.4±7) were randomized to either (ET+NIV+O2) or (ET+O2) or (ET) alone. Patients underwent an exercise training (ET) for 8 weeks and NIV was carried out with oxygen during exercise training. RESULTS: The baseline inspiratory and expiratory pressures were 12.0±1.5 cmH20 and 5.1±0.8 cmH20, respectively. In ET+NIV+O2 group, residual volume and total lung capacity decreased significantly (-305.0±489.1 and -325.0±524.8, both p=0.05, respectively). No significant change was found in lung functions in ET+O2 patients. There were significant increases in Pimax and Pemax in ET+NIV+O2 group and there was an increase in only Pimax in ET patients. The decrease in blood lactate level was not significant. Dyspnea improved only in ET+O2 group (-2.4±2.7, p=0.005). The increase in walking distance was better in ET+NIV+O2 group than ET+O2 patients. Symptom domain of SGRQ was significantly decreased only in ET+NIV+O2 group (-21.8+18.9, p=0.002) and the total score of SGRQ was improved in ET+O2 group. There was an improvement in depression only in ET+NIV+O2 group (-2.8+2.8, p=0.006). CONCLUSIONS: The addition of NIV to oxygen during exercise training in patients with severe COPD patients reduces hyperinflation, improves respiratory muscle strength, exercise capacity, symptom domain of SGRQ and depression compared to ET+O2 and ET alone groups. CLINICAL IMPLICATIONS: Adding non-inavsive ventilation to oxygen during exercise training in patients with severe COPD patients is the best adjunct for improving dyspnea by reducing hyperinflation, respiratory muscle strength, exercise capacity, quality of life and depression. We recommend clinicians to use non-invasive ventilation during exercise training in severe COPD patients. DISCLOSURE: The following authors have nothing to disclose: Alev Gurgun, Senay Tuncel, Hale Karapolat, Hatice Uluer No Product/Research Disclosure Information